Takeda Offers To Sell Shire Drug To Get EU's OK For Takeover
Japanese pharmaceutical giant Takeda announced Monday that it has proposed selling a drug used to treat inflammatory bowel diseases that it would gain in its £46 billion ($60 billion) acquisition of...To view the full article, register now.
Already a subscriber? Click here to view full article